Provided by Tiger Trade Technology Pte. Ltd.

TEMA ONCOLOGY ETF

40.78
+0.65291.63%
Post-market: 40.780.00000.00%16:10 EDT
Volume:12.96K
Turnover:528.43K
Market Cap:205.14M
PE:- -
High:41.00
Open:40.29
Low:40.17
Close:40.13
52wk High:47.00
52wk Low:29.28
Shares:5.03M
Float Shares:5.03M
Volume Ratio:0.34
T/O Rate:0.26%
Dividend:0.02
Dividend Rate:0.05%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

1 Drugs Could Ease Back and Knee Pain, but Doctors Say There are Risks for Older Adults

Dow Jones
·
Yesterday

BofA Securities Adjusts Eli Lilly Price Target to $1,341 From $1,344, Maintains Buy Rating

MT Newswires Live
·
Yesterday

Analysts Have Conflicting Sentiments on These Healthcare Companies: Envista Holdings (NVST), Bristol-Myers Squibb (BMY) and Eli Lilly & Co (LLY)

TIPRANKS
·
Yesterday

Eli Lilly announces new TOGETHER-PsO trial data

TIPRANKS
·
Yesterday

Lilly Says Phase 3b Together-PsO Data Show Broader Biomarker Shifts with Taltz Plus Zepbound vs Taltz Alone

Reuters
·
Yesterday

Eli Lilly price target lowered to $1,341 from $1,344 at BofA

TIPRANKS
·
Yesterday

Eli Lilly - Taltz and Zepbound Together Show Greater Reductions in Inflammatory Immune Activity

THOMSON REUTERS
·
Yesterday

Eli Lilly: Improvements were Maintained or Further Improved Through Week 52, with Safety Consistent with Known Profile of Each Respective Medicine

THOMSON REUTERS
·
Yesterday

New Phase 3B Data on Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) Advance Understanding of the Interconnected Immune and Metabolic Biology in Adults with Psoriasis and Obesity

THOMSON REUTERS
·
Yesterday

Top 3 Biotech Stocks To Watch In October 2026

Simply Wall St.
·
Yesterday

Legend Biotech Corporation : JP Morgan Cuts Target Price to $33 from $35

THOMSON REUTERS
·
Yesterday

RBC would be buyers of Revolution Medicines after FDA docs ‘overreaction’

TIPRANKS
·
Yesterday

Revolution Medicines selloff ‘overdone and misguided,’ says TD Cowen

TIPRANKS
·
Yesterday

Revolution Medicines Falls on Pancreatic Cancer Drug Data Concerns

Reuters
·
Yesterday

Lilly’s Oral Orforglipron Trial Targets Early Obesity Risks, Raising the Stakes in Weight-Loss Pharma

TIPRANKS
·
Yesterday

Revolution trading down after daraxonrasib review docs, says Stifel

TIPRANKS
·
Yesterday

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Yesterday

Starbucks Explored Acquisition of Chipotle in Bid to Create Restaurant Industry Mega-Merger

Deep News
·
Oct 08

1s Could Offer Unexpected Relief from Back and Knee Pain, but Doctors Urge Caution

Dow Jones
·
Oct 08

Roche, Zealand Pharma's Latest Obesity Study Doesn't Move the Needle

Dow Jones
·
Oct 08